We are live on ! Find out more
KXA

KPCB XII Associates Portfolio holdings

AUM $738K
1-Year Est. Return 3.15%
This Fund
S&P 500
This Quarter Est. Return
-31.62%
1 Year Est. Return
-3.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$738K
AUM Growth
-$34.8M
Cap. Flow
-$34.5M
Cap. Flow %
-4,674.12%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$34.5M

Sector Composition

Rank Sector Weight
1 Materials 100%
2 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRS
1
DELISTED
Amyris Inc.
AMRS
$738K 100%
252,834
INSP icon
2
Inspire Medical Systems
INSP
$1.46B
-396,406
Closed -$34.5M

Similar funds

KPCB XII Associates's Q3 2020 Portfolio in Review

As of Q3 2020, KPCB XII Associates held 2 positions worth $738K, down 98% from $35.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KPCB XII Associates withdrew a net $34.5M in Q3 2020, closing 1 position. Its most notable exit was Inspire Medical Systems, an estimated $34.5M position sold in full.

By sector, the portfolio is most concentrated in Materials at 100% of assets, up from 3% a quarter earlier, followed by Healthcare.

  • KPCB XII Associates fully exited Inspire Medical Systems in Q3 2020, selling an estimated $34.5M.
  • KPCB XII Associates's ten largest holdings make up 100% of its $738K portfolio in Q3 2020.
  • KPCB XII Associates opened 0 new positions and closed 1 in Q3 2020.
  • KPCB XII Associates's portfolio value fell 98% quarter-over-quarter to $738K.

Based on KPCB XII Associates's 13F filing for Q3 2020, filed 20 Oct 2020.